Condition
Benign Uterine Disease
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (2)
Trial Status
Completed5
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT02065453Not ApplicableCompletedPrimary
Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy
NCT01683890UnknownPrimary
Study on Bladder and Sexual Function Change After Simple Hysterectomy
NCT01893086Phase 3CompletedPrimary
Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy
NCT01861067Phase 3CompletedPrimary
LESS-TLH Versus LESS-LAVH
NCT01880710Not ApplicableCompletedPrimary
Total Versus Subtotal Abdominal Hysterectomy
NCT01217866CompletedPrimary
A Retrospective Review of Enseal Laparoscopic Vaginal Assisted Hysterectomy (LAVH) Versus Traditional LAVH
Showing all 6 trials